Akums Drugs & Pharmaceuticals

Haridwar, India
Tablets Capsules Oral Solid Dose Injectables Soft Gels Syrups Topicals Nutraceuticals API
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (10) ○ EMA GMP ○ MHRA GMP

Quick Facts: Akums Drugs & Pharmaceuticals

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Haridwar, India
Modalities
Tablets, Capsules, Oral Solid Dose, Injectables, Soft Gels, Syrups, Topicals, Nutraceuticals, API
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Akums Drugs & Pharmaceuticals

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesTablets, Capsules, Oral Solid Dose, Injectables, Soft Gels, Syrups, Topicals, Nutraceuticals, API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (9 modalities)

Recent News 10 articles

news Wed, 12 Au
Earnings Beat: Akums Drugs and Pharmaceuticals Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - webull.com
Source →
news Tue, 11 Au
Buy Akums Drugs and Pharmaceuticals; target of Rs 850: ICICI Securities - TradingView
Source →
news Tue, 11 Au
Akums Drugs, CDSL, Ceigall India, Power Mech In Focus After Q1; ICICI Securities Sees Up To 22% Upside — Check Ratings - NDTV Profit
Source →
news Thu, 13 Au
Akums Drugs and Pharmaceuticals Ltd (BOM:544222) (Q1 2027) Earnings Call Highlights: CDMO ... - Yahoo Finance
Source →
news Thu, 13 Au
Akums Drugs hosts investor meet at Antique Healthcare conf on Aug 25 - scanx.trade
Source →
news Mon, 23 Fe
Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint - Yahoo Finance
Source →
news Mon, 10 Au
Earnings call transcript: Akums Drugs beats revenue estimates in Q1 2026 - Investing.com
Source →
news Mon, 10 Au
Akums Q1 FY27 Revenue Rises 13.9% To ₹1,167 Crore - BW Healthcare World
Source →
news Mon, 10 Au
AKUMS: Strong Q1 growth driven by CDMO, margin expansion, and strategic acquisition in cosmetics - TradingView
Source →
news Fri, 07 Au
Akums Lifesciences Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Source →

Frequently Asked Questions About Akums Drugs & Pharmaceuticals

What is Akums Drugs & Pharmaceuticals's CDMO Signal Score?
Akums Drugs & Pharmaceuticals has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Akums Drugs & Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Akums Drugs & Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Biofarma Group
Padua, Italy
Tablets, Capsules, Softgels, Gummies, Probiotics, Vitamins & Minerals, Dietary Supplements, Functional Foods, Nutraceuticals, Medical Devices (Class I/II)
Sirio Pharma
Shantou, China
Softgels, Hard Capsules, Gummies, Tablets, Dietary Supplements, Functional Foods, Nutraceuticals, OTC Products
Pierre Fabre CDMO
Toulouse, France
Pharmaceutical lozenges (hard-boiled sugar, medicated), Tablets, Capsules, Non-sterile liquids, Sterile injectables (fill-finish), APIs (botanical/synthetic), mAb/ADC (clinical batches)
Aenova Group
Starnberg, Germany
Softgel Capsules, Oral Solid Dose, Semi-Solids, Sterile Injectables, Nutraceuticals
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines